Analyst firms · Oppenheimer · MS
Oppenheimer MS price target and rating history
Morgan Stanley (MS) · Finance
Oppenheimer rates Morgan Stanley (MS) Underperform with a $111 price target, as of its latest action on Jun 30, 2026. It has published 5 rating actions on MS since July 2021, including 1 upgrade and 3 downgrades. Across 3 firms with a MS price target in the last 12 months, the median target is $210.
- Current rating
- Underperform
- Price target
- $111
- Median target, all firms
- $210
- Actions on MS
- 5
Oppenheimer price target on MS
Every Oppenheimer rating on MS
- Jun 30, 2026
- Jul 17, 2024
- May 3, 2022
- Sep 29, 2021
- Jul 16, 2021
How other firms rate MS
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| TD Cowen | Hold | $210 | Oct 8, 2026 |
| Erste Group | Hold | Oct 8, 2026 | |
| HSBC | Hold | $219 | Sep 28, 2026 |
| Oppenheimer | Underperform | Jun 30, 2026 | |
| UBS | Buy | $196 | Apr 7, 2026 |
| Wolfe Research | Outperform | Nov 24, 2025 |
Questions about Oppenheimer and MS
- What is Oppenheimer's price target for MS?
- Oppenheimer's latest stated price target for Morgan Stanley (MS) is $111, from its action on May 3, 2022.
- What is Oppenheimer's rating on MS?
- Oppenheimer rates MS Underperform, a bearish rating, as of Jun 30, 2026.
- When did Oppenheimer last change its view on MS?
- On Jun 30, 2026, Oppenheimer downgrades to Underperform from Perform.
- How does Oppenheimer's MS target compare with other analysts?
- Across 3 firms with a MS price target in the last 12 months, the median target is $210.
More MS rating histories
- Erste Group4
- HSBC5
- UBS3
- Wolfe Research3
- Keefe, Bruyette & Woods3
- Wells Fargo4
- Odeon Capital5
- Citigroup3
- RBC Capital Markets3
All Oppenheimer ratingsMS news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.